|
GB1061943A
(en)
|
1964-09-10 |
1967-03-15 |
Carter S Ink Co |
Marking composition
|
|
NL154600B
(nl)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3766162A
(en)
|
1971-08-24 |
1973-10-16 |
Hoffmann La Roche |
Barbituric acid antigens and antibodies specific therefor
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4294817A
(en)
|
1977-11-25 |
1981-10-13 |
International Diagnostic Technology, Inc. |
Method of fluoro immunoassay
|
|
US4233402A
(en)
|
1978-04-05 |
1980-11-11 |
Syva Company |
Reagents and method employing channeling
|
|
US4313927A
(en)
|
1979-10-19 |
1982-02-02 |
Ames-Yissum Ltd. |
Immunoassay method for detecting viral antibodies in whole blood samples
|
|
US4334016A
(en)
|
1980-06-19 |
1982-06-08 |
The Wistar Institute Of Anatomy And Biology |
Human osteogenic sarcoma cell line and use thereof for immunofluorescent antibody test
|
|
JPS5896026A
(ja)
|
1981-10-30 |
1983-06-07 |
Nippon Chemiphar Co Ltd |
新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
|
|
DE3380726D1
(en)
|
1982-06-24 |
1989-11-23 |
Japan Chem Res |
Long-acting composition
|
|
FR2543570B1
(fr)
|
1983-03-31 |
1985-08-09 |
Pasteur Institut |
Anticorps monoclonaux anticytomegalovirus humains, hybridomes secreteurs de ces anticorps et polypeptides porteurs d'un determinant antigenique sequentiel de cytomegalovirus humains
|
|
US4617379A
(en)
|
1983-06-14 |
1986-10-14 |
Miles Laboratories, Inc. |
High titer cytomegalovirus immune serum globulin
|
|
GB8404368D0
(en)
|
1984-02-20 |
1984-03-28 |
Cogent Ltd |
Monoclonal antibodies to human cytomegalovirus
|
|
US6100064A
(en)
|
1984-04-06 |
2000-08-08 |
Chiron Corporation |
Secreted viral proteins useful for vaccines and diagnostics
|
|
FR2563630B1
(fr)
|
1984-04-27 |
1988-02-19 |
Pasteur Institut |
Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
|
|
US4783399A
(en)
|
1984-05-04 |
1988-11-08 |
Scripps Clinic And Research Foundation |
Diagnostic system for the detection of cytomegalovirus
|
|
US4743562A
(en)
|
1984-08-21 |
1988-05-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Purified human cytomegalovirus protein
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US4950595A
(en)
|
1984-09-28 |
1990-08-21 |
Teijin Limited |
Mouse-human hybridoma which produces antivirus-human antibody, process for preparation thereof, and antivirus-human monoclonal antibody
|
|
US4808518A
(en)
|
1985-02-11 |
1989-02-28 |
University Of Tennessee Research Corporation |
Recovery of cytomegalovirus antigen and use thereof in an assay
|
|
US4804627A
(en)
|
1985-05-09 |
1989-02-14 |
Sloan-Kettering Institute For Cancer Research |
Method for cloning lymphoblastoid cells
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
WO1987003602A1
(fr)
|
1985-12-06 |
1987-06-18 |
Teijin Limited |
Anticorps monoclonal humain contre le virus megalocytique et procede de preparation dudit anticorps
|
|
US4831175A
(en)
|
1986-09-05 |
1989-05-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
|
|
US5153311A
(en)
|
1986-11-24 |
1992-10-06 |
The Children's Hospital, Incorporated |
Immunogenic glycoproteins of human cytomegalovirus gCII
|
|
US5126130A
(en)
|
1986-11-24 |
1992-06-30 |
The Childrens Hospital Incorporated |
Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
|
|
LU86752A1
(fr)
|
1987-01-30 |
1988-08-23 |
Univ Bruxelles |
Procede de production d'anticorps monoclonaux humains(igg)anticytomegalovirus et anticorps monoclonaux ainsi obtenus
|
|
FI884924L
(fi)
|
1987-10-28 |
1989-04-29 |
Oncogen |
Humanimmuglobulin som producerats med hybrid-dna-teknik.
|
|
US5180813A
(en)
|
1989-03-24 |
1993-01-19 |
University Of Iowa Research Foundation |
Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
|
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
|
WO1991004277A1
(en)
|
1989-09-14 |
1991-04-04 |
Children's Biomedical Research Institute |
Monoclonal antibodies specific to cytomegalovirus glycoprotein
|
|
WO1991005876A1
(en)
|
1989-10-20 |
1991-05-02 |
Children's Biomedical Research Institute |
Human cytomegalovirus-specific monoclonal antibody cocktail
|
|
GB9008223D0
(en)
|
1990-04-11 |
1990-06-13 |
Royal Free Hosp School Med |
Improvements relating to the detection of viruses
|
|
DE4035174A1
(de)
|
1990-11-06 |
1992-05-07 |
Biotest Ag |
Verfahren zur bestimmung von proteinen in koerperfluessigkeiten und mittel zur durchfuehrung des verfahrens
|
|
US5997878A
(en)
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
|
JPH053794A
(ja)
*
|
1991-06-26 |
1993-01-14 |
Green Cross Corp:The |
抗サイトメガロウイルスヒトモノクローナル抗体およびその産生細胞
|
|
DE4128684A1
(de)
|
1991-08-29 |
1993-03-04 |
Behringwerke Ag |
Hcmv-spezifische peptide, mittel dazu und ihre verwendung
|
|
ES2125248T3
(es)
|
1992-04-10 |
1999-03-01 |
Thomas Totterman |
Metodo de deteccion de una infeccion cmv.
|
|
SE9201281L
(sv)
|
1992-04-23 |
1993-10-24 |
Bioinvent Int Ab |
Nya humana monoklonala antikroppar och förfarande för framställning därav
|
|
JPH05260961A
(ja)
*
|
1992-05-21 |
1993-10-12 |
Teijin Ltd |
サイトメガロウイルスに対するヒト・モノクローナル抗体を産生するハイブリドーマ
|
|
GB9221654D0
(en)
*
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
|
ES2131188T3
(es)
|
1993-01-21 |
1999-07-16 |
Erna Moller |
Prevencion y tratamiento de citomegalovirus utilizando aminopeptidasa.
|
|
CA2153790A1
(en)
|
1993-01-28 |
1994-08-04 |
Lars G. Ostberg |
Human monoclonal antibodies to cytomegalovirus
|
|
US5750106A
(en)
|
1993-01-28 |
1998-05-12 |
Novartis Ag |
Human monoclonal antibodies to cytomegalovirus
|
|
AU6777594A
(en)
|
1993-04-30 |
1994-11-21 |
Scripps Research Institute, The |
Human monoclonal antibodies to human cytomegalovirus, and methods therefor
|
|
US5595721A
(en)
|
1993-09-16 |
1997-01-21 |
Coulter Pharmaceutical, Inc. |
Radioimmunotherapy of lymphoma using anti-CD20
|
|
EP0702083A3
(de)
|
1994-07-26 |
1997-01-15 |
Biotest Ag |
Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien
|
|
US5783383A
(en)
|
1995-05-23 |
1998-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of detecting cytomegalovirus (CMV)
|
|
US6019980A
(en)
|
1995-06-07 |
2000-02-01 |
Connaught Laboratories Limited |
Nucleic acid respiratory syncytial virus vaccines
|
|
US5800981A
(en)
|
1996-02-22 |
1998-09-01 |
University Of Limburg |
Human cytomegalovirus antigen and its use
|
|
ES2187796T3
(es)
|
1996-07-12 |
2003-06-16 |
Organon Teknika Bv |
Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano.
|
|
US6291437B1
(en)
|
1996-08-14 |
2001-09-18 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for retarding the development of atherosclerotic lesions
|
|
US6156498A
(en)
|
1997-01-30 |
2000-12-05 |
Cedars-Sinai Medical Center |
Establishment of HHV-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting HHV-8 infection
|
|
US6183752B1
(en)
|
1997-02-05 |
2001-02-06 |
Pasteur Merieux Serums Et Vaccins |
Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
|
|
AU8063798A
(en)
|
1997-06-19 |
1999-01-04 |
Regents Of The University Of California, The |
Secretory immunoglobulin produced by single cells and methods for making and using same
|
|
NZ502626A
(en)
|
1997-07-18 |
2002-09-27 |
Connaught Lab |
Vaccines comprising a nucleic acid vector encoding the G protein of respiratory syncytial virus (RSV)
|
|
US20030180257A1
(en)
|
1997-11-14 |
2003-09-25 |
Mark Parrington |
Alphavirus vectors for paramyxovirus vaccines
|
|
DE19756214C1
(de)
|
1997-12-17 |
1999-02-25 |
Biotest Ag |
Polypeptide mit Aminosäuresequenzen aus dem N-terminalen Bereich von gp116 und deren Verwendung bei der Diagnostik, Prophylaxe und Therapie
|
|
CA2322380C
(en)
|
1998-03-12 |
2008-10-14 |
Genentech, Inc. |
Method of preventing the death of retinal neurons and treating ocular diseases
|
|
ATE249846T1
(de)
|
1998-06-29 |
2003-10-15 |
Wolfgang Bergter |
Antivirale und antiretrovirale radioimmunpharmaka auf der basis von alpha- und beta-strahlern
|
|
RU2133472C1
(ru)
|
1998-09-16 |
1999-07-20 |
Унитарное государственное Московское предприятие по производству бактерийных препаратов |
Способ диагностики активной стадии цитомегаловирусной инфекции человека
|
|
MY133346A
(en)
|
1999-03-01 |
2007-11-30 |
Biogen Inc |
Kit for radiolabeling ligands with yttrium-90
|
|
US20020102208A1
(en)
|
1999-03-01 |
2002-08-01 |
Paul Chinn |
Radiolabeling kit and binding assay
|
|
ITMI20012160A1
(it)
|
2001-10-18 |
2003-04-18 |
Edoardo Marchisio |
Sistema immunoenzimatico per la caratterizzazione antigenica dell'infezione attiva da cytomegalovirus e cmv confirmation test
|
|
US6828113B2
(en)
|
2002-03-21 |
2004-12-07 |
Cornell Research Foundation, Inc. |
IgM antibodies to the 70 kDa heat shock protein as a marker for cytomegalovirus infection
|
|
AU2002258689C1
(en)
|
2002-04-01 |
2008-04-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
|
|
RU2239453C2
(ru)
*
|
2002-12-03 |
2004-11-10 |
Федеральное государственное унитарное предприятие " Научно-производственное объединение по медицинским иммунобиологическим препаратам " Микроген" |
Препарат иммуноглобулина человека против цитомегаловируса и способ его получения
|
|
WO2004076677A2
(en)
|
2003-02-26 |
2004-09-10 |
Institute For Research In Biomedicine |
Monoclonal antibody production by ebv transformation of b cells
|
|
WO2004076645A2
(en)
|
2003-02-27 |
2004-09-10 |
University Of Massachusetts |
Compositions and methods for cytomegalovirus treatment
|
|
US20060216302A1
(en)
|
2003-02-28 |
2006-09-28 |
Robert Root-Bernstein |
Immunological markers
|
|
RU2412202C2
(ru)
|
2004-06-21 |
2011-02-20 |
Медарекс, Инк. |
Антитела рецептора 1 интерферона альфа и их применение
|
|
BE1016287A6
(nl)
|
2004-07-14 |
2006-07-04 |
Picanol Nv |
Gaapvormingsonderdeel voor een weefmachine en weefmachine.
|
|
US7976845B2
(en)
|
2004-11-29 |
2011-07-12 |
The Council Of The Queensland Institute Of Medical Research |
Human cytomegalovirus immunotherapy
|
|
US7988971B2
(en)
|
2005-03-14 |
2011-08-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Human monoclonal antibodies against Hendra and Nipah viruses
|
|
EP1974020B1
(en)
|
2005-12-16 |
2011-06-15 |
Ribovax Biotechnologies SA |
Methods for obtaining immortalized antibody secreting cells
|
|
JPWO2007094423A1
(ja)
|
2006-02-15 |
2009-07-09 |
株式会社イーベック |
ヒトサイトメガロウイルスに結合するヒトのモノクローナル抗体並びにその抗原結合部分
|
|
US7977457B2
(en)
|
2006-05-19 |
2011-07-12 |
Teva Pharmaceutical Industries Ltd. |
Fusion proteins, uses thereof and processes for producing same
|
|
EP3031469B1
(en)
|
2006-06-07 |
2023-08-23 |
The Trustees Of Princeton University |
Cytomegalovirus surface protein complex for use in vaccines and as a drug target
|
|
JP5351041B2
(ja)
|
2006-12-15 |
2013-11-27 |
リボバックス バイオテクノロジーズ ソシエテ アノニム |
ヒトサイトメガロウィルス（ｈｍｃｖ）に対する抗体
|
|
GB0700133D0
(en)
|
2007-01-04 |
2007-02-14 |
Humabs Llc |
Human cytomegalovirus neutralising antibodies and use thereof
|
|
US7947274B2
(en)
|
2007-01-04 |
2011-05-24 |
Humabs, LLC. |
Human cytomegalovirus neutralising antibodies and use thereof
|
|
WO2008120203A2
(en)
|
2007-03-29 |
2008-10-09 |
Technion Research & Development Foundation Ltd. |
Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases
|
|
US20080248042A1
(en)
|
2007-04-05 |
2008-10-09 |
Irccs Centro Di Riferimento Oncologico Di Aviano, |
Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc
|
|
WO2009024445A1
(en)
|
2007-08-22 |
2009-02-26 |
Ribovax Biotechnologies Sa |
Antibodies against human cytomegalovirus (hcmv)
|
|
US7763261B2
(en)
|
2007-12-19 |
2010-07-27 |
Dcb-Usa Llc |
Anti-human cytomegalovirus antibodies
|
|
UA106354C2
(ru)
|
2008-07-16 |
2014-08-26 |
Инститьют Фо Рисерч Ин Байомедсин |
Антитела, нейтрализующие цитомегаловирус человека, и их применение
|
|
WO2010007463A1
(en)
|
2008-07-16 |
2010-01-21 |
Humabs Llc |
Human cytomegalovirus neutralising antibodies and use thereof
|